Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ointment preparation for treating duck leg diseases and preparation method thereof

A technology of duck leg disease and ointment, which is applied in the field of ointment preparation for the treatment of duck leg disease and its preparation, can solve problems such as damage to the soft tissue of the bottom of the foot, cause leg diseases, and difficulty in walking in breeding ducks, so as to promote blood flow and drug release And penetrating, promote wound healing effect

Inactive Publication Date: 2011-07-06
TIANJIN RINGPU BIO TECH
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1. Too much weight: During the breeding period, the feeding amount of the breeding ducks is higher than the standard feeding amount during the restricted feeding, resulting in excessive body size and too much fat deposition, which makes it difficult for the breeding ducks to walk, causing leg diseases;
[0005] 2. Unbalanced nutrition, lack of calcium, phosphorus, vitamin D or other minerals: vitamin D, calcium, and phosphorus are important components of bones; vitamin D can promote the absorption and transformation of Ca and P
In addition, if the ground is too hard, it will also damage the soft tissue on the bottom of the foot, causing soft tissue hyperplasia and joint deformation;

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The prescription of the ointment containing nanoscale gentamicin sulfate and cefaclor:

[0027] components

Dosage

Gentamicin Sulfate

5.0% (W / W)

Cefaclor

3..0% (W / W)

Menthol

1.0% (W / W)

stearic acid

20.0% (W / W)

White Vaseline

20.0% (W / W)

Glyceryl monostearate

12.0% (W / W)

glycerin

15.0% (W / W)

Tween 80

6.0% (W / W)

Ethyl p-hydroxybenzoate

0.2% (W / W)

purified water

Add to 100% (W / W)

[0028] Preparation method:

[0029] (1) Dissolve the nano-scale main drug gentamicin sulfate and cefaclor in an appropriate amount of warm purified water, fully dissolve and mix, and stir to obtain solution A.

[0030] (2) Mix menthol, glyceryl stearic acid, glycerin, and white petrolatum, heat and melt in a water bath at 70-80°C, and stir to obtain oil phase B.

[0031] (3) Take an appropriate amount of purified water, add ethyl p-hydroxybenzoate to dissolve and let ...

Embodiment 2

[0034] The prescription of the ointment containing nanoscale gentamicin sulfate and cefaclor:

[0035] components

Dosage

Gentamicin Sulfate

8.0% (W / W)

Cefaclor

2.0% (W / W)

Menthol

1.5% (W / W)

stearic acid

20.0% (W / W)

White Vaseline

20.0% (W / W)

Glyceryl monostearate

12.0% (W / W)

glycerin

10.0% (W / W)

Tween 80

2.0% (W / W)

Ethyl p-hydroxybenzoate

0.2% (W / W))

purified water

Add to 100% (W / W)

[0036] Preparation method:

[0037] (1) Dissolve the nano-scale main drug gentamicin sulfate and cefaclor in an appropriate amount of warm purified water, fully dissolve and mix, and stir to obtain solution A.

[0038] (2) Mix menthol, glyceryl stearic acid, glycerin, and white petrolatum, heat and melt in a water bath at 70-80°C, and stir to obtain oil phase B.

[0039] (3) Take an appropriate amount of purified water, add ethyl p-hydroxybenzoate to dissolve and let ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an ointment containing nano-scale gentamycin sulfate and cefaclor for treating duck leg diseases and a preparation method thereof. The main medicaments of the ointment preparation are nano-scale powder, the ointment preparation can be applied to skin directly, and has the advantages of strengthening the target effect of medicaments, convenient administration, quick absorption, direct achievement to deeper skin, strong sterilization, small side effect and the like. The ointment preparation can effectively treat the duck leg diseases due to duck leg infection caused by staphylococcus, pseudomonas aeruginosa and other bacteria, so that the ointment containing the nano-scale gentamycin sulfate and the cefaclor can sufficiently play the effect of the medicament when treating the duck leg diseases.

Description

technical field [0001] The invention belongs to the technical field of veterinary medicine, in particular to an ointment preparation for treating duck leg disease and a preparation method thereof. Background technique [0002] Duck is a traditional breed of waterfowl in my country. my country's current breeding volume ranks first in the world. The annual output value of the waterfowl industry exceeds 100 billion yuan, which has become a new growth point for Chinese farmers to increase their income. However, in the breeding and management process of breeding ducks for meat, there are often leg diseases in breeding ducks due to various reasons. Generally, the onset begins at the age of 60 days, and the incidence rate can be as high as 7%-15%, but the mortality rate is not high. It also occurs during the laying period, especially in the late laying period. And cause the duck egg production rate, the fertilization rate to drop and the high elimination rate of the breed duck, ca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7036A61K31/545A61K9/06A61P31/04
Inventor 聂丽娜夏雪林程志瑛
Owner TIANJIN RINGPU BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products